News & Analysis on the Clinical Development and Manufacture of Large Molecule Drugs
AB Sciex has launched what it claims is the first commercially available ultra-low flow electrospray ionization instrument that links CE (capillary electrophoresis) technology to mass spectrometry.
NICE has asked Alexion Pharmaceuticals to explain why its drug Soliris costs over thirty times that of other monoclonal antibodies.
The high street of tomorrow is likely to be a mix of supermarkets, banks and biopharmaceutical manufacturing plants according to one expert who says urban drug production has significant advantages for Pharma firms and patients.
Regeneron has denied it has plans for a fill/finish facility to complement its new $300m (€219m) biomanufacturing plant in Limerick, Ireland.